Close

TESARO (TSRO) Presents Statistically Significant Phase 3 ENGOT-OV16/NOVA Trial Results at ESMO

October 10, 2016 6:40 AM EDT Send to a Friend
Over the weekend, TESARO, Inc. (NASDAQ: TSRO) and ENGOT, the European Network for Gynaecological Oncological Trial groups, today announced the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login